Development and Internal Validation of a Nomogram-Based Model to Predict Three-Year and Five-Year Overall Survival in Patients with Stage II/III Colon Cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries: global cancer statistics 2018. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Fu J, Huang Y, Yang J, et al. Clinical characteristics and prognosis of young patients with colorectal cancer in Eastern China. World J Gastroenterol. 2013;19(44):8078–8084. doi:10.3748/wjg.v19.i44.8078
   PubMed Web of Science ®Google Scholar
• Li M, Gu J. Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol. 2005;11(30):4685–4688. doi:10.3748/wjg.v11.i30.4685
   PubMed Web of Science ®Google Scholar
• Stormark K, Soreide K, Soreide JA, et al. Nationwide implementation of laparoscopic surgery for colon cancer: short-term outcomes and long-term survival in a population-based cohort. Surg Endosc. 2016;30(11):4853–4864. doi:10.1007/s00464-016-4819-8
   PubMed Web of Science ®Google Scholar
• Sobrero A, Lonardi S, Rosati G, et al. FOLFOX or CAPOX in stage II to III colon cancer: efficacy results of the Italian three or six colon adjuvant trial. J Clin Oncol. 2018;36(15):1478–1485. doi:10.1200/JCO.2017.76.2187
   PubMed Web of Science ®Google Scholar
• Hari DM, Leung AM, Lee JH, et al. AJCC cancer staging manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment. J Am Coll Surg. 2013;217:181–190. doi:10.1016/j.jamcollsurg.2013.04.018
   PubMed Web of Science ®Google Scholar
• Webber C, Gospodarowicz M, Sobin LH, et al. Improving the TNM classification: findings from a 10-year continuous literature review. Int J Cancer. 2014;135:371–378. doi:10.1002/ijc.28683
   PubMed Web of Science ®Google Scholar
• Zhao P, Ma J, Qin SZ, et al. China cancer clinical yearbook. Chinese Journal of Frontier Medicine. 2017, 9(5):153–160.
   Google Scholar
• Su BB, Shi H, Wan J. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection. World J Gastroenterol. 2012;18(17):2121–2126. doi:10.3748/wjg.v18.i17.2121
   PubMed Web of Science ®Google Scholar
• Van Halteren HK, Houterman S, Verheij CD, et al. Anaemia prior to operation is related with poorer long-term survival in patients with operable rectal cancer. Eur J Surg Oncol. 2004;30(6):628–632. doi:10.1016/j.ejso.2004.04.014
   PubMed Web of Science ®Google Scholar
• Maeda K, Shibutani M, Otani H, et al. Inflammation-based factors and prognosis in patients with colorectal cancer. World J Gastroenterol Oncol. 2015;7(8):111–117.
   PubMed Web of Science ®Google Scholar
• Huang L, Fang J, Wu J, et al. The value of preoperative serum tumor markers combined with blood routine indicators in evaluating the prognosis of patients with colorectal cancer. Chin J Gastrointest Surg. 2018;21(12):1421–1426.
   Google Scholar
• Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358(11):1160–1174. doi:10.1056/NEJMra0707704
   PubMed Web of Science ®Google Scholar
• Haseba M, Hidaka S, Tsuji T, et al. Detection of p53 gene mutations by nonisotopic RNase cleavage assay as a predictor of poor prognosis in colorectal cancers. Dig Dis Sci. 2003;48(10):1984–1989. doi:10.1023/A:1026126522278
   PubMed Web of Science ®Google Scholar
• Liu YJ, Yan PS, Li J, Jia JF. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. World J Gastroenterol. 2005;11(42):6601–6606. doi:10.3748/wjg.v11.i42.6601
   PubMed Web of Science ®Google Scholar
• Dalchau R, Kirkley J, Fabre JW. Monoclonal antibody to a human brain granulocyte-T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat. Eur J Immunol. 1980;10(10):745–749. doi:10.1002/eji.1830101004
   PubMed Web of Science ®Google Scholar
• Valentini V, Van Stiphout RG, Lammering G, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29(23):3163–3172. doi:10.1200/JCO.2010.33.1595
   PubMed Web of Science ®Google Scholar
• Pavlou M, Ambler G, Seaman SR, et al. How to develop a more accurate risk prediction model when there are few events. BMJ. 2015, 11;351:h3868. doi:10.1136/bmj.h3868
   Google Scholar
• Abasse Kassim S, Tang W, Abbas M, et al. Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China. Cancer Epidemiol. 2019;62:101565. doi:10.1016/j.canep.2019.07.004
   PubMed Web of Science ®Google Scholar
• Kanakis G, Kaltsas G. Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs). Best Pract Res Clin Gastroenterol. 2012;26:791–802. doi:10.1016/j.bpg.2012.12.006
   PubMed Web of Science ®Google Scholar
• Nozoe T, Rikimaru T, Mori E, et al. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcino- ma. J Surg Oncol. 2010;94(2):132–137. doi:10.1002/jso.20577
   Web of Science ®Google Scholar
• Pietrzyk L, Plewa Z, Denisow-Pietrzyk M, et al. Diagnostic power of blood parameters as screening markers in gastric cancer patients. Asian Pac J Cancer Prev. 2016;17(9):4433–4437.
   PubMedGoogle Scholar
• Sun Z, Wang F, Zhou Q, et al. Pre-operative to post-operative serum carcinoembryonic antigen ratio is a prognostic indicator in colorectal cancer. Oncotarget. 2017;8(33):54672–54682. doi:10.18632/oncotarget.17931
   PubMedGoogle Scholar
• Kim CG, Ahn JB, Jung M, et al. Preoperative serum carcinoembryonic antigen level as a prognostic factor for recurrence and survival after curative resection followed by adjuvant chemotherapy in stage III colon cancer. Ann Surg Oncol. 2017;24(1):227–235. doi:10.1245/s10434-016-5613-5
   PubMed Web of Science ®Google Scholar
• Gur AS, Atahan K, Aladag I, et al. The efficacy of nutrition risk screening-2002 (NRS-2002) to decide on the nutritional support in general surgery patients. Bratisl Lek Listy. 2009;110:290–292.
   PubMed Web of Science ®Google Scholar
• Peng J, Zhang R, Zhao Y, et al. The prognostic value of preoperative prognostic nutrition index in patients with stage III colon cancer and its correlation with systemic inflammatory response markers. Cancer. 2019;038(001):10–22.
   Google Scholar
• Zhou H, Wang W, Zhang R, et al. Prognostic nutrition index for evaluating the prognosis of locally advanced colorectal cancer. J Guizhou Med Univ. 2019;44(3):335–340.
   Google Scholar
• Benson AB 3rd, Venook AP, Al-Hawary MM, et al. Rectal cancer, Version 2.2018, NCCN clinical practice guidelines in oncology. JNCCN. 2018;16(7):874–901.
   Google Scholar
• Sanoff HK, Carpenter WR, Sturmer T, et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012;30(21):2624–2634. doi:10.1200/JCO.2011.41.1140
   PubMed Web of Science ®Google Scholar
• Kawai K, Ishihara S, Yamaguchi H, et al. Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: a multicenter retrospective study. Eur J Surg Oncol. 2015;41(4):457–465. doi:10.1016/j.ejso.2015.01.026
   PubMed Web of Science ®Google Scholar
• Li C, Pei Q, Zhu H, et al. Survival nomograms for stage III colorectal cancer. Medicine. 2018;97(49):e13239. doi:10.1097/MD.0000000000013239
   PubMed Web of Science ®Google Scholar
• Zhong JW, Yang SX, Chen RP, et al. Prognostic value of lymphovascular invasion in patients with stage III colorectal cancer: a retrospective study. Med Sci Monit. 2019;25:6043–6050. doi:10.12659/MSM.918133
   PubMed Web of Science ®Google Scholar
• Wu Q, Wang WJ, Huang YQ, Fang SY, Guan YJ. Nomograms for estimating survival in patients with liver-only colorectal metastases: a retrospective study. Int J Surg. 2018;60:1–8. doi:10.1016/j.ijsu.2018.10.032
   PubMed Web of Science ®Google Scholar
• Zhang JY, Gong Z, Gong YW, Guo WJ. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer. Jpn J Clin Oncol. 2019;49(5):438–446. doi:10.1093/jjco/hyz035
   PubMed Web of Science ®Google Scholar